生物材料全球市场规模、份额和增长分析（按类型、应用）- 2023-2030 年行业预测

Global Biomaterials Market Size, Share, Growth Analysis, By Type(Natural Biomaterial, Metallic Biomaterial), By Application(Neurology, Cardiology) - Industry Forecast 2023-2030

出版日期: 2023年04月29日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球生物材料市场规模预计将从 2022 年的 1559 亿美元增至 2030 年的 4381 亿美元，在预测期内（2023-2030 年）复合年增长率为 15.4%。人口老龄化和慢性疾病流行正在推动对生物材料的需求。

本报告研究和分析了全球生物材料市场，提供市场动态和前景、细分市场分析、公司简介等。

内容

执行摘要

调查方法

母市场分析

主要市场考虑因素

技术分析
价格分析
供应链分析
价值链分析
市场生态系统
知识产权分析
贸易分析
启动分析
原材料分析
创新矩阵
管道产品分析
宏观经济指标
主要投资分析
关键成功因素
争用程度

市场动态与展望

市场动态
驱动程序
机会
制约因素
任务
监管情况
波特五力分析
对未来混乱的特殊考虑

全球生物材料市场：按类型

市场概况
天然生物材料
金属生物材料
陶瓷生物材料
高分子生物材料

全球生物材料市场：按应用

市场概况
神经
心
骨科
眼科
伤口护理
牙科
整形外科
其他用途

全球生物材料市场规模：按地区

市场概况
北美
美国
加拿大
欧洲
德国
西班牙
法国
英国
欧洲其他地区
亚太地区
中国
印度
日本
韩国
亚太地区其他地区
拉丁美洲
巴西
其他拉丁美洲地区
中东和非洲
海湾合作委员会国家
南非
其他中东和非洲地区

竞争格局

前 5 家公司的比较
主要公司的市场定位（2021 年）
主要市场公司采用的策略
关键成功策略
最近的市场活动
主要公司的市场份额（2021 年）

主要公司简介

Evonik Industries AG
Corbion
BASF SE
Royal DSM NV
Invibio Ltd.
Carpenter Technology Corporation
Celanese Corporation
Berkeley Advanced Biomaterials, Inc.
Cam Bioceramics B.V.
Collagen Matrix, Inc.
Bayer AG
Medtronic plc
Wright Medical Group N.V.
Zimmer Biomet Holdings, Inc.
Stryker Corporation
Danaher Corporation
Becton, Dickinson and Company
Thermo Fisher Scientific Inc.
3M Company
DuPont de Nemours, Inc.

简介目录

Product Code: SQMIG35H2027

Biomaterials Market size was valued at USD 135.4 billion in 2021 and is poised to grow from USD 155.9 billion in 2022 to USD 438.1 billion by 2030, growing at a CAGR of 15.4% in the forecast period (2023-2030).

The global biomaterials market refers to the industry that involves the production and application of materials that are compatible with biological systems, such as human tissues and organs. Biomaterials play a crucial role in medical and healthcare applications, including implantable medical devices, tissue engineering, drug delivery systems, and regenerative medicine. These materials are designed to interact with biological systems without causing adverse reactions and promote healing and tissue regeneration.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomaterials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The Global biomaterials market is segmented on the basis of type, application, and region. Based on the type, the market is segmented into natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial. Based on the application, the market is segmented as neurology, cardiology, orthopedics, ophthalmology, wound care, dental, plastic surgery, and other applications. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The aging population and the increasing prevalence of chronic diseases drive the demand for biomaterials. Biomaterials are used in various medical procedures, such as joint replacements, cardiovascular implants, and dental applications, to enhance the quality of life for patients suffering from age-related conditions or chronic illnesses. Technological advancements in medical devices and procedures fuel the demand for biomaterials. The development of innovative biomaterials enables the design of more effective and biocompatible medical implants, prosthetics, and drug delivery systems, leading to improved patient outcomes and expanded treatment options.

Restraint

The development and production of biomaterials involve extensive research, rigorous testing, and compliance with regulatory standards. These processes can be expensive, leading to higher costs associated with biomaterials. The high cost can limit their widespread adoption, particularly in resource-constrained healthcare systems.

Market Trends

There is a growing emphasis on bioactive and biodegradable biomaterials that can interact with the body's tissues, promote healing, and gradually degrade over time. These materials reduce the need for additional surgeries for implant removal, enhance patient comfort, and support the regeneration of functional tissues. The integration of 3D printing and additive manufacturing technologies in the production of biomaterials offers new opportunities for customization and precision in medical applications. 3D printing allows for the fabrication of complex structures, patient-specific implants, and scaffold designs, revolutionizing the field of personalized medicine and tissue engineering.